Introduction {#S1}
============

As in mammals, *Drosophila* ISCs maintain gut homeostasis by dividing to replace lost cells. ISCs generate transient progeny, enteroblasts (EBs), that can differentiate into absorptive enterocytes (ECs) or secretory enteroendocrine cells (EEs)^[@R1],\ [@R2]^. These epithelial cells grow on a basement membrane (BM) overlaying the visceral muscle (VM), which together with ECs, EEs, and EBs comprises the stem cell niche. Fly midgut homeostasis is regulated by Notch, cytokine/JAK-STAT, EGFR/Ras/MAPK, JNK, Hippo, insulin, Wnt, PDGF/VEGF, Hh and BMP/TGFβ signaling^[@R3]^. The various niche cells (EBs, ECs and VM) collectively provide these signals to regulate ISC growth, self-renewal and differentiation. Delta-Notch signaling is the primary trigger of EB to EC differentiation^[@R1],\ [@R2],\ [@R4]^. ISCs express a Notch (N) ligand, Delta (Dl), which activates the Notch receptor in EBs and promotes their differentiation into ECs^[@R2],\ [@R4]^. Loss of N, Dl, or other Notch pathway components in progenitor cells (ISCs and EBs) results in the rapid expansion of differentiation-defective, *escargot*- positive (*esg^+^*), Delta- positive (Dl^+^) ISC-like cells that form multi-layered neoplastic tumors, typically admixed with excess Prospero-positive (Pros^+^) EE cells that are also produced^[@R1],\ [@R2],\ [@R4]-[@R6]^.

According to current models differentiation-defective stem cells should remain dependent on growth and survival factors in their niche^[@R7]^, and require secondary mutations to initiate the run-away growth characteristic of tumors^[@R8]^. While the importance of immune cells, fibroblasts, and vasculature recruited as a tumor builds its microenvironment is appreciated^[@R9]^, how tumor initiating cells interact with the stem cell niche prior to microenvironment formation is poorly understood. In flies, differentiation-defective larval neural or adult germline stem cell tumors can overgrow in their respective organs, but whether the stem cell niche is required to propel the growth of these cells has not been tested^[@R10]^. In the fly midgut, the growth of ISC-derived tumors (*e.g Apc^−^* or *Ras^V12^ dlg^−^*) has been proposed to require niche signals^[@R10]-[@R13]^, however the mechanisms controlling the activation of these signals, and the functional importance of the niche cells that produce them, have not been directly tested. In the mouse intestine, stem-like tumor initiating cells (*LGR5^+^APC^−^*) in early adenomas remain associated with Paneth cells - an essential part of the normal ISC niche^[@R14]^ - but whether these tumor initiating cells are dependent on growth signals from Paneth cells is unknown^[@R15]^. Here we examine how differentiation-defective *Notch^−^* ISC tumors grow in the adult fly ISC niche.

*Notch^−^* ISC tumor cells are proliferative endocrine progenitors {#S2}
==================================================================

We first investigated the identity of the tumor cells that arise from depleting *Notch* with RNAi in progenitors, using the *esg^ts^GAL4* system (*esg^ts^*). We found *N^−^* tumors to be an admixture of Pros^high^ EE-like cells and neoplastic ISC-like cells that express high levels of ISC markers (Dl^high^ *esg*^high^) but also low levels of EE markers (Pros) ([Supplementary Fig. 1a-a', c-c'''](#SD2){ref-type="supplementary-material"}). ISC-like tumors cells did not show markers of active Notch signaling (*SuH-lacZ*) or EC differentiation (Pdm1; [Supplementary Fig. 1b-b', d-d'''](#SD2){ref-type="supplementary-material"}). mRNA-seq analysis showed that ISC-like *N*^−^ tumor cells (Dl^high^ *esg*^high^) expressed many ISC-associated genes (*i.e. Dl* and *spdo*)^[@R2],\ [@R4],\ [@R6],\ [@R16]^ and EE-associated genes (*i.e. pros* and *Allatostatin*, *AstA*)^[@R1],\ [@R2],\ [@R17]^ ([Supplementary Fig. 1g-j](#SD2){ref-type="supplementary-material"}), and functional tests showed that these cells differentiated into EEs, rather than ECs, when *N^RNAi^* expression was extinguished ([Supplementary Fig. 1e-f'](#SD2){ref-type="supplementary-material"}). Together these data indicate that ISC-like tumor cells are actually committed EE precursors rather than multipotent progenitors. We did not find mitotic (phospho-Ser 10-Histone 3 positive) Pros^+^ EE-like cells within the tumors; indeed only *esg^+^* ISC-like tumor cells were proliferative ([Fig. 3a](#F3){ref-type="fig"}, [5c](#F5){ref-type="fig"}). To determine the role of the excess EEs in tumor growth, we suppressed Notch signaling by expressing RNAi towards *Suppressor of Hairless* (*SuH*), in which tumors without excess EEs are generated ([Supplementary Fig. 5d](#SD6){ref-type="supplementary-material"})^[@R17]^. In this case large *esg^+^* tumors formed similar to those seen with *N^−^* tumors containing EEs, indicating that the excess EEs present in most *N^−^* tumors have little if any role in tumor growth.

Gut epithelial stress promotes ISC tumor initiation {#S3}
===================================================

To understand how the niche might contribute to ISC-derived tumorigenesis, we investigated how *N^−^* tumors initiate. Despite a presumably uniform block to differentiation by the expression of *N^RNAi^* using *esg^ts^*, tumors were not detected in all experimental animals. This indicated that simply blocking differentiation was not sufficient for tumor initiation. Hence we asked whether tumor initiation might be dependent on environmental factors. Previous reports showed that stress or damage to the midgut (*e.g.* by enteric infection) activates JNK and YAP/Yki signaling and that this stimulates the production of cytokines (Upd2,3) that are mitogenic for ISCs^[@R18]-[@R23]^. Previous work also showed that enteric infection could increase ISC tumor outgrowth and reduce host survival^[@R13],\ [@R18]^. For instance Apidianakis et al.^[@R13]^ found that the frequency of tumor initiation from *N^−^* ISCs could be enhanced by enteric infection. We confirmed these results by performing enteric infection with *Pseudomonas entomophila* (*P.e.*) prior to initiating ISC tumors by inducing *N^RNAi^* ([Fig. 1f](#F1){ref-type="fig"}; [Supplementary Fig. 6f](#SD7){ref-type="supplementary-material"}). Since JNK signaling can be activated by enteric infection, we tested whether JNK signaling in ECs might influence the frequency of tumor initiation, as suggested by Apidianakis et al.^[@R13]^. We expressed a brief pulse of activated Hemipterous (Hep^Act^, Jun Kinase Kinase), with the EC-specific *Myo1A^ts^GAL4- UAS* system (*Myo1A^ts^*), and then afterwards used Flp/FRT-mediated recombination to induce ISC clones mutant for the Notch signaling component, *neuralized* (*neur*), to inhibit stem cell differentiation ([Fig. 1a](#F1){ref-type="fig"}, [Supplementary Fig. 3a-c](#SD4){ref-type="supplementary-material"}). Neur is an E3 ubiquitin ligase required for Notch signaling^[@R5]^ and its loss results in ISC tumors consisting of Dl^+^ ISC- like cells and Pros^+^ EE cells^[@R4]^, similar to *N^RNAi^*. Similarly to infection, delivering a pulse of JNK activity to ECs prior to Notch suppression resulted in more tumors per midgut ([Fig. 1b](#F1){ref-type="fig"}) and more flies bearing tumors ([Fig. 1c](#F1){ref-type="fig"}). However the JNK pulse did not affect tumor outgrowth after initiation ([Fig. 1d](#F1){ref-type="fig"}), indicating that this transient stress specifically promoted tumor initiation. As JNK is known to induce the Upd cytokines^[@R18]^ and thereby activate ISCs for division, we asked whether mutant ISC division might be a prerequisite for tumor initiation. To test this we co-expressed *Cyclin E* and *string* (Cdc25), a gene combination that promotes ISC division^[@R24]^, together with *N^RNAi^* in progenitor cells. This also greatly increased tumor incidence, confirming that ISC division is sufficient to promote tumor initiation ([Fig. 1e](#F1){ref-type="fig"}; [Supplementary Fig. 6g](#SD7){ref-type="supplementary-material"}). These results suggest that, in addition to loss of differentiation capacity, the formation of small clusters of ISC-like cells by stress-induced stem cell divisions may be a prerequisite for tumor formation.

ISC tumor initiation and outgrowth requires autonomous Spi/EGFR signaling {#S4}
=========================================================================

We next sought to define the tumor autonomous factors that drive tumor growth after initiation. EGFR signaling is required for ISC proliferation^[@R25]-[@R28]^, so we checked its role. *N^−^* or *neur^−^* tumor growth increased the expression of the EGFR ligands *spi* and *vn* ([Fig. 2g](#F2){ref-type="fig"}, [Supplementary Fig. 2b](#SD3){ref-type="supplementary-material"}) and mRNA-seq of FACS-isolated *esg^+^* tumor cells revealed that the tumor cells themselves produced more *spi* but not *vn* ([Fig. 2h](#F2){ref-type="fig"}). Notably, the highest level of *spi* expression in normal midguts was in *Dl^+^* ISCs ([Supplementary Fig. 2a](#SD3){ref-type="supplementary-material"}). The expression of the EGFR pathway target *argos* was also increased in the tumor cells ([Fig. 2h](#F2){ref-type="fig"}), which had higher levels of activated MAPK (ppMAPK) than normal ISCs ([Fig. 2a-d](#F2){ref-type="fig"}). To determine whether EGFR/MAPK signaling was necessary for *N^−^* tumor growth we expressed the MAPK phosphatase 3 (Mkp3), or RNAi against EGFR or Spi in the tumor cells themselves. These treatments suppressed tumor growth. Thus *N^−^* tumor cells, like normal ISCs, require EGFR/MAPK activity to grow ([Fig. 3a-d,e](#F3){ref-type="fig"}). Depleting *spi* for 2 weeks in wild-type animals did not deplete progenitor cells, suggesting that Spi, unlike the EGFR^[@R25],\ [@R26]^ is not an essential survival factor for normal ISCs. Remarkably, while flies bearing *N^−^* ISC tumors died within 10 days, depleting *spi* in the tumor cells resulted in viable flies with tumors that remained small even after 30 days ([Fig. 3e-f](#F3){ref-type="fig"}). These results indicate that autocrine Spi/EGFR/MAPK signaling is required for ISC tumor growth. Since tumor initiation also requires ISC mitosis ([Fig. 1](#F1){ref-type="fig"}), we speculate that Spi signaling may only be effective when multiple ISC-like Spi-expressing tumor cells are juxtaposed in a cluster, and that mitosis generates these clusters.

ISC tumors promotes enterocyte detachment, extrusion, and death {#S5}
===============================================================

Tumor cells might compete with normal epithelial cells for adhesion to the basement membrane (BM), which in the midgut consists of extracellular matrix (ECM) components including collagen IV, laminin and perlecan^[@R29],\ [@R30]^. Cell extrusion due to cell overcrowding has been observed in fish and mouse epithelia, and proposed as a mechanism for maintaining tissue homeostasis^[@R31]^. Accelerating epithelial replacement in the midgut results in the rapid loss of older ECs^[@R25]^, possibly also by cell extrusion. But little data is available on the extrusion of normal cells at tumor boundaries, or how this might impact tumor growth. In our case light and electron microscopy showed that ECs adjacent to and overlying the tumors were detached from the BM, and that a subset of these detached ECs were apoptotic ([Fig. 4a-b](#F4){ref-type="fig"}, [Supplementary Fig. 4a-a', d](#SD5){ref-type="supplementary-material"}). mRNA-seq analysis showed that *N^−^* tumor growth induced the pro-apoptotic genes *rpr*, *skl* and particularly *grim* in non-tumor cells ([Supplementary Fig. 4b-c](#SD5){ref-type="supplementary-material"}). Consistently, we observed pyknotic nuclei in non-tumor cells either adjacent or apical to 38.5% of *neur^−^* tumors (n=45) whereas pyknotic nuclei were rarely found in tumor-free regions. This suggested that ECs might initiate apoptosis during or after apical extrusion. Pyknotic nuclei were never associated with tumors smaller than 20 cells, suggesting that EC death depended upon the tumors achieving a minimum critical mass. To test whether apoptosis was required for EC detachment and extrusion we generated *neur^−^* tumors amongst ECs expressing the apoptosis inhibitor p35 ([Fig. 4c](#F4){ref-type="fig"}). Non-apoptotic p35-expressing ECs could be found apical to tumors, suggesting that apoptosis was not required for EC detachment. However, tumors generated in p35-expressing epithelia were smaller than tumors growing in normal epithelia ([Fig. 4h](#F4){ref-type="fig"}, [Supplementary Fig. 3d-e](#SD4){ref-type="supplementary-material"}), indicating that EC apoptosis enhanced tumor growth. Thus, *N^−^* tumors grow by promoting EC detachment from the BM, and their apoptosis- dependent death.

JNK and Yki activity in tumor-adjacent enterocytes promotes tumor growth {#S6}
========================================================================

Epithelial stress activates both JNK and Hippo/Yki signaling in midgut ECs^[@R18],\ [@R20],\ [@R21],\ [@R23]^. Using reporters for JNK (*puc-lacZ*) and Yki (*ex-lacZ*) activity, we observed high JNK and Yki activity in detached ECs adjacent and apical to larger *N^−^* or *Dl^−^* ISC tumors, but not in the *esg^+^* tumor cells themselves ([Fig. 4e-e', 4g-g'](#F4){ref-type="fig"}). Interestingly, both JNK and Yki activity spread several EC diameters away from tumors ([Fig. 4e-e', 4g-g'](#F4){ref-type="fig"}, [Supplementary Video 1](#SD10){ref-type="supplementary-material"}-[3](#SD12){ref-type="supplementary-material"}). To test whether JNK signaling in ECs affected tumor growth, we generated *neur^−^* tumors amongst ECs expressing a dominant-negative form of JNK (Bsk^K53R^) or *bsk^RNAi^*, or the JNK phosphatase *puckered* (Puc). To avoid effects on tumor initiation these JNK suppressors were activated after tumor induction ([Fig. 4c](#F4){ref-type="fig"}). Expression of Bsk^K53R^, *bsk^RNAi^,* or Puc specifically in ECs suppressed *neur^−^* tumor growth ([Fig. 4i](#F4){ref-type="fig"}, [Supplementary Fig. 3f-g](#SD4){ref-type="supplementary-material"}). Conversely, increasing JNK signaling in ECs by expressing Hep (JNK) or Hep^Act^ resulted in larger tumors ([Fig. 4i](#F4){ref-type="fig"}) and increased pyknotic nuclei around tumors. This increased apoptosis was not due directly to increased JNK activity, since rapid EC detachment or pyknotic nuclei were not observed in regions without tumors. By determining the skewness and kurtosis for each tumor population we found that tumor populations were positively skewed, such that the majority of tumors were smaller than the mean size (see [Fig. 4](#F4){ref-type="fig"}, [6](#F6){ref-type="fig"} and [Supplementary Fig. 7](#SD8){ref-type="supplementary-material"} legends). Decreasing tumor growth by JNK suppression increased the positive skew in the tumor size distribution, such that even more tumors were smaller than the mean and even fewer were larger. In contrast, enhancing tumor growth by overexpressing Hep or Hep^Act^ in ECs consistently shifted tumor sizes closer to a normal distribution. Using the same approach, we tested the non-tumor autonomous function of Hippo signaling in ISC tumor growth by expressing *yki^RNAi^* or Warts (Wts), an inhibitor of Yki, in ECs. This also inhibited *neur^−^* tumor growth ([Fig. 4j](#F4){ref-type="fig"}, [Supplementary Fig. 3h-i](#SD4){ref-type="supplementary-material"}). Thus the induction of JNK and Yki activity in ECs surrounding larger ISC tumors contributes indirectly to tumor growth.

Tumor growth induces mitogenic signals in the niche {#S7}
===================================================

In studying the tumorous *neur^−^* clones we noted increased mitoses both inside and outside of the tumors ([Fig. 5a,b](#F5){ref-type="fig"}). In addition, most of the mitoses in tumor cells were at tumor boundaries rather than tumor interiors ([Fig. 5c-d](#F5){ref-type="fig"}). Both observations suggested that the tumors might stimulate the production of diffusible mitogenic signals by surrounding niche cells. Previous studies showed that EC apoptosis or ectopic JNK or Yki activity in ECs can stimulate the expression of the EGFR ligands *Vn* and *Krn*, and the *Upd2* and *Upd3* cytokines, all of which are stress-inducible ISC mitogens^[@R18],\ [@R20]-[@R22],\ [@R25]^. Thus we suspected that stress from the *N^−^* tumors might also activate these niche-derived mitogens. Indeed, mRNA-seq and qPCR experiments on tumor-bearing midguts revealed increases in *vn, upd2* and *upd3* ([Fig. 2g](#F2){ref-type="fig"}, [6e](#F6){ref-type="fig"}, [Supplementary Fig. 2b](#SD3){ref-type="supplementary-material"}, [5a,d](#SD6){ref-type="supplementary-material"}). mRNA-seq experiments on sorted tumor cells showed that both *vn* and *upd3* expression increased in the surrounding niche rather than in tumor cells ([Fig. 2g-h](#F2){ref-type="fig"}, [6e](#F6){ref-type="fig"}, [Supplementary Fig. 5b](#SD6){ref-type="supplementary-material"}) whereas *upd2* increased in tumor cells and also the niche (EC, VM) ([Fig. 6e](#F6){ref-type="fig"}, [Supplementary Fig. 5b](#SD6){ref-type="supplementary-material"}). In contrast to a previous report^[@R32]^ *Upd1* induction was detected neither inside nor outside of *N^−^* tumors ([Fig. 6e](#F6){ref-type="fig"}, [Supplementary Fig. 5b-d](#SD6){ref-type="supplementary-material"}). Using a reporter we observed high *vn* expression in visceral muscle adjacent to the tumors ([Fig. 2f-f'](#F2){ref-type="fig"}), but not in regions devoid of tumors ([Fig. 2e-e'](#F2){ref-type="fig"}). *in situ* hybridization showed that many ECs adjacent to or located apically to ISC tumors expressed high levels of *upd3* mRNA ([Fig. 6b-c'](#F6){ref-type="fig"}, [Supplementary Figs. 6a-b'](#SD7){ref-type="supplementary-material"}), which was undetectable in controls ([Fig. 6a-a'](#F6){ref-type="fig"}). Cytokine induction was not due to EE cell expansion nor to altered enteric bacterial load ([Supplementary Fig. 5d](#SD6){ref-type="supplementary-material"}, [6c-e](#SD7){ref-type="supplementary-material"}), and so we infer that it was a direct result of tumor-induced EC stress. mRNA-seq experiments also revealed that the PDGF/VEGF (PVR) ligand *Pvf2*, the insulin-like peptide *Dilp3* and *wg*, a Wnt, were non-autonomously induced by *N^−^* tumors, presumably in ECs and/or VM ([Supplementary Fig. 2c-d](#SD3){ref-type="supplementary-material"}). These signals have also been implicated as ISC mitogens or survival factors^[@R29],\ [@R33]-[@R37]^ and might also promote tumor growth.

Upd cytokines produced by tumor-adjacent enterocytes drive tumor growth {#S8}
=======================================================================

The most potent known effectors of ISC proliferation are the Upd cytokines. We found that tumor cells had high STAT activity ([Fig. 6d,d'](#F6){ref-type="fig"}; [Supplementary Fig. 5h-i'](#SD6){ref-type="supplementary-material"}), expressed the STAT target *socs36E* ([Fig. 6e](#F6){ref-type="fig"}), and could be stimulated to grow faster by increasing Upd signaling ([Fig 6f](#F6){ref-type="fig"}). Expressing oncogenic Ras (Ras^V12G^) in ECs - a treatment that induces JNK activity ([Supplementary Fig. 7](#SD8){ref-type="supplementary-material"}) and Upd3^[@R25]^ in ECs - also strongly accelerated *N^−^* tumor growth ([Supplementary Fig. 7e](#SD8){ref-type="supplementary-material"}, [3l-m](#SD4){ref-type="supplementary-material"}). A previous report^[@R38],\ [@R39]^ showed that STAT is required in *N^−^* ISC tumors for them to produce EEs, but the role of JAK-STAT signaling in tumor growth was not addressed. Expressing a dominant negative form of the Upd receptor, Domeless (Dome^ΔCYT^) in *N^−^* tumors strongly suppressed their growth without altering cell identity ([Fig. 6f](#F6){ref-type="fig"}, [Supplementary Fig. 5g-g'', i-j'](#SD6){ref-type="supplementary-material"}), indicating that Upd signaling was required for tumor growth.

A recent study of *Apc^−^* tumors in the fly midgut^[@R11]^ also reported the induction of an *upd3* reporter gene (*upd3-lacZ*) in tumor-adjacent ECs, and showed that *domeless* and *Stat92E* were required in the tumor cells for optimal tumor growth^[@R11]^. However, the requirement for *upd3* was not functionally tested, and the *Apc^−^* tumor cells themselves also expressed *upd3-lacZ*^[@R11]^, leaving it unclear whether niche-derived Upd3 was important for tumor growth. To resolve this question we directly tested the requirement for niche-derived Upd2 and Upd3. First, we measured *N^−^* tumor growth in mutant flies completely lacking *upd2* (*upd2Δ*), *upd3* (*upd3Δ*) or both genes (*upd2-3*Δ). Second, to determine whether Upd2 and Upd3 were specifically required from ECs, rather than systemically, we generated *neur^−^* ISC tumors in flies in which *upd2* or *upd3* were specifically suppressed in ECs using targeted RNAi. In both cases tumor growth was suppressed ([Fig. 6g-h](#F6){ref-type="fig"}, [Supplementary Fig. 3j-k](#SD4){ref-type="supplementary-material"}, [5e-f](#SD6){ref-type="supplementary-material"}), confirming that the production of Upd cytokines by ECs promotes ISC tumor growth.

JNK, Yki and Upd3 are induced by detachment of enterocytes from the visceral muscle {#S9}
===================================================================================

Cordero *et al.*^[@R11]^, proposed that hyperplastic *Apc^−^* tumors induce *upd3* expression by stimulating EGFR signaling in surrounding ECs. However, we did not observe increased dpMAPK staining in ECs neighboring *N^−^* ISC tumors, even though these tumors produced high levels of Spi ([Fig. 2a-d, h](#F2){ref-type="fig"}). Rather, we found high JNK and Yki activity and *upd3* expression in ECs surrounding ISC tumors. To determine if EC detachment from the BM and VM was involved in the induction of JNK and Yki activity and Upd3 expression, we first scored how detachment correlated with these markers. Tumor-adjacent ECs positive for *puc-lacZ*, *ex-lacZ* or *upd3.1*-lacZ were scored in three categories: fully attached, partially detached or fully detached. *upd3.1-lacZ* was observed nearly exclusively in fully or partially detached ECs, whereas *puc-lacZ* and *ex-lacZ* were also observed in fully attached tumor-adjacent ECs ([Fig 7a, c](#F7){ref-type="fig"}). When we scored only very strong signals for these markers, the trends were more obvious: high *upd3.1-lacZ* signal was predominantly confined to partially and fully detached ECs, whereas high Jnk and Yki signals were less tightly correlated with detachment and spread further from the tumors ([Fig 7b](#F7){ref-type="fig"}, [Fig 4e-e', g-g'](#F4){ref-type="fig"}). These data indicate that JNK and Yki activity and *upd3* expression are induced in detached ECs, and also that the induction of JNK and Yki activity can spread to neighboring fully attached ECs ([Supplementary Fig. 8a](#SD9){ref-type="supplementary-material"}).

To determine if EC detachment is sufficient to induce JNK and Yki activity in ECs we expressed the matrix metalloproteinase Mmp-1, which is known to cleave ECM components. We also depleted integrins, which mediate cell adhesion to the ECM, from ECs. Loss of integrins from ISCs has been shown to affect their asymmetric division, proliferation and maintenance^[@R40]-[@R42]^, whereas loss of β integrin subunits from ECs can induce ISC proliferation^[@R42]^. MMP-1 expression in ECs resulted in their detachment from the VM ([Fig. 7d-d'''](#F7){ref-type="fig"}). Detaching ECs in this way caused them to lose βPS1 (Myospheroid, Mys) and to induce JNK and Yki activity ([Fig. 7d-d''', e-e'](#F7){ref-type="fig"}) and *upd3* expression ([Fig. 7f-f'](#F7){ref-type="fig"}). Interestingly, we also found that ECs detached by tumors had reduced βPS1 expression ([Fig. 8d-d'](#F8){ref-type="fig"}). Our mRNA-seq analysis of ECs revealed that in addition to βPS1 (*mys*), αPS1 (*multiple edematous wing*, *mew*) and αPS3 (*scab*, *scb*) were highly expressed in ECs ([Supplementary Fig. 8b-c'''''](#SD9){ref-type="supplementary-material"}), consistent with previous reports^[@R41]^. We found that depleting βPS1, αPS1 or both αPS3 and αPS4, but not αPS2 (*inflated, if*) in ECs, increased the number of detaching ECs and induced ISC proliferation ([Fig. 8a-c](#F8){ref-type="fig"}). These ECs showed decreased basal surfaces and increased JNK activity ([Fig. 8b-b'](#F8){ref-type="fig"}). JNK activity was often observed in partially detached ECs ([Fig. 7a](#F7){ref-type="fig"}, [8b-b'](#F8){ref-type="fig"}) suggesting that decreased ECM adhesion, rather than decreased proximity to the VM, induces stress signaling. Notably, activating JNK directly by expressing Hep^Act^ in ECs did not result in their rapid detachment, indicating that JNK activation is not likely to be causal for EC detachment. Together these data demonstrate that EC detachment from the BM is sufficient to stimulate JNK and Yki activity, and *upd3* expression ([Supplementary Fig. 8a](#SD9){ref-type="supplementary-material"}).

ISC tumors and enterocytes compete for the substratum {#S10}
=====================================================

A previous study in the fly midgut found that reducing integrins in *N^−^* or *Apc^−^* tumor cells inhibited their growth, and that these tumors were eliminated from the epithelium^[@R41]^. We confirmed this interesting observation, which suggests that tumor cells may compete with normal cells for BM attachment. To test the importance of tumor/EC competition in another way, we generated tumors amongst ECs in which integrins were depleted by targeted RNAi. We expected that this might reduce the ability of these ECs to compete with the tumor cells for BM attachment. Indeed, we found that these treatments enhanced tumor growth ([Fig. 8e](#F8){ref-type="fig"}). Together these data support the idea that tumor cells compete with ECs for attachment to the BM, via integrin-mediated adhesion.

Discussion {#S11}
==========

Here we describe a step-wise series of events during the earliest stage of tumor development in a stem cell niche ([Fig. 8f](#F8){ref-type="fig"}). First, the combination of environmentally triggered mitogenic signaling and a mutation that compromises differentiation generates small clusters of differentiation-defective stem-like cells. Autocrine (Spi/EGRF) signaling between these cells then promotes their expansion into clusters, which quickly reach a size capable of physically disrupting the surrounding epithelium and driving the detachment and apical extrusion of surrounding epithelial cells (ECs). This loss of normal cells appears to involve tumor cell/epithelial cell competition via integrin-mediated adhesion. Subsequently the loss of epithelial integrity (specifically, EC detachment) triggers stress signaling (JNK, Hpo/Yki) in the surrounding epithelium and underlying visceral muscle, and these stressed tissues respond by producing cytokines (Upd2,3) and growth factors (Vn, Pvf, Wg, dILP3). These signals are normally used within the niche to activate stem cells for epithelial repair, but in this context they further stimulate tumor growth in a positive feedback loop. It is noteworthy that in this example a single mutation that blocks differentiation is sufficient to drive early tumor development, even without secondary mutations in growth signaling pathways that might make the tumor initiating cells growth factor- and niche-independent (*e.g.* Ras, PTEN). Thus tumor cell-niche interactions can be sufficient to allow tumor-initiating cells to rapidly expand, increasing their chance to acquire secondary mutations that might enhance their growth or allow them to survive outside their normal niche^[@R8]^. Our study highlights the importance of investigating the factors that control paracrine stem cell mitogens and survival signals in the niche environment. Tumor-niche interactions may be important to acquire a sizable tumor mass prior to the recruitment of a tumor-specific microenvironment that supports further tumor progression. A careful analysis of similar interactions in other epithelia, such as in the lung, skin or intestine could yield insights relevant to the early detection, treatment, and prevention of cancers in such tissues.

Methods {#S12}
=======

Fly stocks {#S13}
----------

All experiments were performed using 5-10 day old, adult female *Drosophila melanogaster*. The following fly stocks were used: *esgGAL4; tubGAL80^ts^ UAS-GFP* (*esg^ts^*)*, myo1AGAL4; tubGAL80^ts^ UAS-GFP* (*myo1A^ts^*)*, tubGAL80^ts^ UAS-GFP; how(24B)GAL4, Dl^05151^* (*Dl-lacZ*), *Gbe-Su(H)-lacZ*, *puc^E69^* (*puc-lacZ*), *10XSTAT-DGFP*, *upd3.1-lacZ, vn^P1749^*(*vn-lacZ*)*, UAS-CycE, UAS-hep^Act^, UAS-Mkp3*, *UAS-p35, UAS-Ras^V12G^, UAS-stg, UAS-upd, FRT82B* and the MARCM 82B stock: *yw hsFLP UAS-GFP tubGAL4; +; FRT82B tubGAL80* and were previously described in Jiang et al., 2009, 2011. yw hsFLP; myo1AGAL4 tubGAL80^ts^ UAS-GFP; FRT82B neur^IF65^ was generated for this study. *FRT 82B neur^IF65^* was obtained from Hugo Bellen (Baylor College of Medicine, USA); *Rab3-YFP* from Suzanne Eaton (Max Plank Institute of Molecular Cell Biology and Genetics, Germany); *ex^697^* (*ex-lacZ*) from Georg Halder (K.U. Leuven, Belgium); *upd1-lacZ, Gbe*-Su(H)GAL4; tubGAL80ts UAS-GFP and tubGAL80ts; Dl-GAL4, UAS-GFP from Steven Hou (National Cancer Institute, USA); *UAS-hep, UAS-bsk^RNAi^* (GD34138) *and UAS-bsk^K53R^* from Heinrich Jasper (Buck Institute, USA); *upd2Δ, upd3Δ, upd2-3Δ, UAS-upd2^RNAi^* (1) (NIG 5988R-3) *and UAS-upd3^RNAi^* (1) (Agaisse et al., 2003) from Bruno Lemaitre (EPFL, Switzerland); *UAS-puc* from Donald McEwen (UTHSC, San Antonio, USA); *UAS-Mmp1* from Andrea Page-McCaw (Vanderbilt University, USA); *esgGAL4 tubGAL80^ts^ UAS-GFP* from Norbert Perrimon (Harvard Medical School, USA) and *UAS- dome^ΔCYT^* from Tian Xu (Yale University, USA). *UAS-Dl^RNAi^* (3720GD), *UAS-mys^RNAi^* (29619GD), *UAS-N^RNAi^*(100002KK and 27228GD)*, UAS-αPS3-4^RNAi^* (4891GD), *UAS-SuH^RNAi^* (103597KK)*, UAS-upd2^RNAi^*(2) (14664GD), *UAS-upd3^RNAi^* (2) (106869KK) and *UAS-yki^RNAi^* (104523KK) were obtained from the Vienna *Drosophila* RNAi Center (VDRC). *UAS-sc, UAS-wts, UAS-Egfr^RNAi^* (TRiP.JF01696) and *UAS-spi^RNAi^* (TRiP.JF03322) were obtained from the Bloomington *Drosophila* Stock Center. *UAS-mew^RNAi^* (1771R-3) was obtained from the National Institute of Genetics (NIG), Japan.

*Drosophila* genetics {#S14}
---------------------

Flies raised at 18°C were shifted to 29°C to induce *UAS* transgene expression in progenitor cells with *esgGAL4; tubGAL80^ts^* (*esg^ts^*) or in ECs with the *myo1AGAL4; tubGAL80^ts^* (*myo1A^ts^*). To generate MARCM clones, flies were heat shocked at 37°C for 30 minutes and kept at 25°C until dissection. For *myo1A^ts^; FLP-FRT* experiments, flies were heat shocked as described above to generate *neur^IF65^* FLP-FRT tumors and allowed to recover 1 day prior to a second heat shock. After recovery for 1 day, flies were then shifted for 7-8 days to 25°C or 29°C to allow *UAS* transgene expression in ECs with *myo1A^ts^*. Adult flies were orally infected with *Pseudomonas entomophila* as described in Jiang et al., 2009. No statistical method was used to predetermine sample size but typically between 5-20 flies were used per experiment. When selecting animals for an experiment, the parental genotype was not concealed since it was required to select pertinent progeny. Animals were first selected for their genotype and then randomly chosen to be used for an experiment.

Histology {#S15}
---------

After dissection and 8% paraformaldehyde fixation, midguts were washed in PBS, 0.1% Triton X-100, blocked in PBS, 0.1% Trinton X-100, 1% bovine serum albumin (BSA), 2% normal goat serum (NGS) and stained in blocking solution with mouse monoclonal anti-β--PS1 integrin (clone \#CF.6G11, 1:20, Lin et al., 2013), anti- Delta (clone \#C594.9B, 1:100, Ohlstein and Spradling, 2007), anti-Discs Large (clone \#4F3, 1:100) or anti-Prospero (clone \#MR1A, 1:100, Micchelli and Perrimon, 2006) from the Developmental Studies Hybridoma Bank (DHSB), rabbit anti-Prospero (1:2000, from Yuh Nung Jan, UCSF, USA, Bardin et al., 2010), rabbit anti-Pdm-1 (1:1000, from Xiaohang Yang, Institute of Molecular and Cell Biology, Singapore, Jiang et al., 2011), rabbit polyclonal anti-phospho Ser10 histone 3 (1:1000, Upstate Biotechnology/Millipore, \#06-570), rabbit polyclonal anti-β-galactosidase (1:1000, Cappel), chicken polyclonal anti-β-galactosidase (1:1000, Abcam, \#ab9361), mouse monoclonal anti-diphospho-ERK (clone\# MAPK-YT, 1:200, Sigma, \#M8159) and rabbit or chicken polyclonal anti-GFP (1:1000, Life Technologies, \#A11122, \#A10262). Midguts were then washed in PBS 0.1% Triton X-100, stained in PBS, 0.3% Triton X-100, 0.1% BSA with Alexa Fluor- conjugated secondary antibodies (Life Technologies), Alexa Flour 647- phalloidin (Life Technologies) and Hoechst 33258 (Life Technologies), and mounted in Vectashield (Vector Laboratories).

Mitotic indices were determined by counting the number of pH3 positive cells from whole female midguts from 2-3 independent experiments. The mean number of mitoses per midgut and s.e.m. are presented for each genotype or treatment. Cells per tumor were determined by counting the total number of nuclei within Dl^+^ Pros^+^ tumors ≥ 8 cells. The mean cell number per tumor obtained from 3 independent experiments and s.e.m. are presented for each genotype. Before quantifying the number of mitoses per midgut or the number of cells per tumor, the genotype of each sample was concealed. Samples were then randomly analyzed and the genotype was revealed only after completing analysis. Tumor frequency was determined by counting the number of tumors per midgut in affected flies; the mean number of tumors per midgut obtained from 3 independent experiments and s.e.m. is presented for each genotype. Tumor incidence was determined by counting the number of flies (or midguts) with tumors in the population; the mean percent of affected flies obtained from 3 independent experiments and s.e.m. is presented for each genotype.

Statistical Analysis {#S16}
--------------------

Statistical analyses, including the determination of skewness and kurtosis for each tumor population, were performed using GraphPad Prism 5. For data describing mitoses per midgut, cells per tumor, tumor frequency, the Mann-Whitney test (two-sided) was applied to determine statistical significance. For data describing tumor incidence or mitoses at the tumor interior/boundary, the paired t-test (two-sided) was applied to determine statistical significance.

*In situ* hybridization {#S17}
-----------------------

Fluorescent *in situ* hybridization for *upd3* mRNA was performed as described in Jiang et al., 2011. Midguts were dissected, fixed in 8% paraformaldehyde/PBS overnight at 4°C, permeabilized 3 times for 10 minutes in PBST (PBS, 0.1% Triton X-100) and then stored in 70% ethanol. Midguts were then hybridized with a fluorescently labeled (CAL Flour Red 590) DNA 20-mer probes (pool of 48) (Stellaris) against *upd3* transcript.

Light microscopy {#S18}
----------------

Samples were analyzed using Nikon Eclipse Ti, Leica DM5000B, Zeiss LSM 510 and Leica SP5 microscopes. Images were processed with ImageJ (NIH) and Adobe Photoshop CS5. Confocal images are presented as maximal intensity projection of images obtained every 0.25-1.0μm. When comparing protein or transcript levels, each z- stack was acquired with the same laser intensity and gain, maximal intensity projections of identical dimensions were created, and were further similarly processed with Adobe Photoshop CS5, except in the case of [Supplementary Fig. 5j](#SD6){ref-type="supplementary-material"} which was significantly brightened. Representative images presented were obtained from ≥2 independent experiments.

Transmission electron microscopy {#S19}
--------------------------------

Midguts were dissected, fixed in 0.5X Karnovsky's fixative and post-fixed in OsO~4~. Midguts were then dehydrated in ascending concentrations of ethanol, embedded in epon and sectioned to obtain 70-90nm sections. Samples were analyzed with a JEOL 1230 transmission electron microscope with an Orius SC1000 Gatan CCD.

mRNA sequencing of whole midguts and sorted midgut cell populations {#S20}
-------------------------------------------------------------------

Whole midgut RNA was isolated from 15 guts using RNeasy RNA isolation kit (Qiagen) following manufacturer's protocol. Cell type specific profiling was performed as previously described^[@R43]^. Briefly, 100 guts were dissected in RNAse free PBS and treated with 7.5 mg/ml collagenase or 4 mg/ml elastase for 1 hour at 27°C. Dissociated cells were pelleted at 300xg for 15 mins, resuspended in 1X RNAse free PBS, filtered using 25-micron filters (BD Falcon) and sorted using a FACS Aria II sorter (BD Biosciences) with 70 micron nozzle size. To exclude auto fluorescence, gates were set using control midguts from *w^1118^* flies. Cell type- specific GAL4 drivers (*esg-GAL4* (ISCs and enteroblasts), *Dl-GAL4* (ISCs), *Su(H)-GAL4* (enteroblasts), *myo1A-GAL4* (enterocytes), *how*-GAL4 (visceral muscle) and *Rab3*-YFP and *pros-GAL4* (EEs) were used to express green or yellow fluorescent protein (GFP or YFP) to sort each cell population. GFP or YFP- positive cells were sorted based on fluorescence intensity and cell size. A total of 2000 cells were sorted for each sample. Total RNA from each sorted cell type was isolated using the PicoPure RNA isolation kit (Arcturus). 2ng of isolated total RNA was used for RNA amplification using Arcturus^®^ RiboAmp^®^ HS PLUS RNA Amplification Kit for whole midgut and cell type- specific RNA profiling. Total RNA from each sample was reverse transcribed using a T7 promoter sequence containing oligodT primer and SuperScript^®^III Reverse Transcriptase (200-U) enzyme. Random hexamers were used for the second strand synthesis. aRNA was then produced by in vitro transcription using T7 RNA polymerase at 42°C for 6hrs. The amplified RNA (aRNA) integrity was determined with an Agilent 2100 bioanalyzer, enriched for 200-400bp mRNA and used directly for RNA sequencing. Amplified mRNA was then shattered by magnesium-catalyzed hydrolysis and used for cDNA library preparation. Adaptors were ligated and mRNA sequencing was performed using an Illumina HiSeq2000 sequencer with 50 bp read length.

### Data analysis {#S21}

all reads were inspected using Fastqc version 01.0.1 with default settings. Since no trimming was needed, the raw reads were mapped to the reference genome version 70 (ENSEMBL) using tophat2 (version 2.0.9) with default parameters (2 mismatches allowed), boost library 1.54.0, bowtie2 2.1.0 and samtools version 0.1.19. The resulting bam files were converted to sam files using samtools, and subsequently counted using HTSeqcount (0.5.4p5). Ambiguous reads, reads with low quality, unaligned reads, reads with non-unique alignment and reads aligning to non-features were discarded. Differential expression analysis was conducted using edgeR (3.2.4) with filtering for low expressed genes showing a cpm value above 1 in two biological replicates. P-values were adjusted using Benjamini-Hochberg correction. Genes with a cpm \>1, a 1.5-fold change and an adjusted p-value \<0.05 were considered significantly deregulated. The mean normalized expression (RPKM, log~2~) value from 2 independent experiments, adjusted fold change and adjusted p-value for each gene is presented. A Principle Component Analysis (PCA) was conducted using the function prcomp in the stats package of R (3.1.0) with scaling the variables to have unit variance and zero centering based on the mean RPKM values per cell type. Only genes showing RPKM values greater than zero were used for calculation.

Quantitative RT-PCR {#S22}
-------------------

RNA was isolated from 15-20 midguts either using TRIzol or RNAeasy kit (Qiagen), 250-500ng of RNA was used for cDNA synthesis using the iScript cDNA synthesis kit (Bio-Rad) or the Quantitect cDNA synthesis kit (Qiagen). qPCR was performed using the iScript One Step RT-PCR kit with SYBR green (BioRad) or with LightCycler 480 SYBER Green I Master (Roche). SYBR green incorporation during PCR was detected using the iQ5 system (BioRad) or Roche 480 II Lightcycler. The following primers were used: *upd1* F: 5′-CCACGTAAGTTTGCATGTTG-3′, *upd1* R: 5′-CTAAACAGTAGCCAGGACTC-3′, *upd2* F: 5′-CACAAGTGCGGTGAAGCTAA-3′, *upd2* R: 5′-GGCTCTTCTGCTGATCCTTG-3′, *upd3* F: 5′-GCCCTCTTCACCAAACTGAA-3′, *upd3* R: 5′-TTTCTTCTGGATCGCCTTTG-3′, *spi* F: 5′-CCTTCTATTTGCGCTTCGAG-3′, *spi* R: 5′-CGCATGTGGTAGGGTAGCTT-3′, *krn* F: 5′-CGTGTTTGGCAACAACAAGT-3′, *krn* R: 5′-TGTGGCAATGCAGTTTAAGG-3′, *vn* F: 5′-AACGCAGAGGTCACGAAGAT-3′, *vn* R: 5′-GCGCACTATTAGCTCGGAAC-3′, *Dl* F: 5′-TCTGTTTTAGGCGAGGGTTC-3′, *Dl* R: 5′-AAGCTGCAGCCATTAGTTGC-3′, *Ast* F: 5′-CCTGCCGGTCTATAACTTCG-3′ and *Ast* R: 5′-GATCTCGTTGTCCTGGTCGT-3′. We found that *crq* gene expression did not change after ISC tumor growth and thus the expression of each target gene was normalized to crq expression (reference) to ensure equivalent RNA or cDNA input. The primers used to detect crq expression were: *crq* F: 5′-CAGAGCTCTCCTCCGAATTG-3′, *crq* R: 5′-ATGCCGGTGATGAGAAAGAC-3.′ Each assay was performed in triplicate or in quadruplet on ≥ 3 independent biological replicates. Since primer efficiency (E)= 1, the relative expression of each gene was determined using the ΔΔCt method, where ΔΔCt (or log~2~ fold change) is the difference in threshold cycles for the experimental and control samples normalized to the threshold cycles for the reference gene. ΔΔC~t~ = ΔC~t~ (experiment) −ΔC~t~ (control) ΔC~t~ (experiment) or ΔC~t~ (control) = C~t~ target gene − C~t~ reference gene All data are presented as mean fold change (log~2~) with s.e.m.

Quantitation of stress reporter- positive ECs surrounding tumors {#S23}
----------------------------------------------------------------

Fixed midguts were stained with anti- Dlg to outline the lateral boundary of ECs and with anti- Pros to mark EE cells. For *upd3.1*-lacZ, cytoplasmic β-gal signal was used to determine the lateral EC boundary. z-stacks (0.5μm step size) of posterior midgut regions (387.5μm x 387.5μm) bearing *N^−^* tumors were obtained by confocal microscopy. 3- 4 z-stacks were analyzed per genotype. β-gal- positive ECs were classified into the following categories: 1) fully detached ECs (fd): ECs for which tumor cells were found along the entire basal surface of the EC; 2) partially detached ECs (pd), ECs for which tumor cells were observed basally to the EC but not along the entire basal surface; and 3) fully attached ECs (fa), ECs for which no tumor cells were found along their basal surface. Only β-gal- positive ECs that bordered a cluster of *esg^+^* ISC tumor cells were considered tumor-adjacent, and were scored. Rare non- tumor adjacent β-gal- positive ECs were observed but are not reported. *upd3.1*-lacZ and *ex*-lacZ were not observed in *esg^+^* tumors cells; *puc*-lacZ was also observed in EE-like *esg*^low^ Pros^high^ tumor cells and in Pros^+^ EE cells, but these were excluded from the analysis. β-gal intensity (high or low) in ECs was determined prior to its classification as fully attached, partially detached or fully detached.

Survival analysis {#S24}
-----------------

100 adult flies per genotype were transferred to food vials (10 flies/vial) and shifted to 29°C. The number of dead flies in each vial were scored every 2 days and surviving adults were transferred to fresh food vials. Flies expressing *N^RNAi^* with *esg^ts^* were scored until 50 flies were found dead. For all other genotypes, the number of dead flies was scored for 14 days.

Antibiotic treatment and detection of enteric bacteria levels {#S25}
-------------------------------------------------------------

50 adults were fed for 3-4 days at 22°C normal fly food or food containing antibiotics (10,000U/ml penicillin, 10mg/ml streptomycin (1:150). Midguts were dissected from 20-25 flies, homogenized and used for total genomic DNA isolation. gDNA was then used for PCR for bacterial 16S rDNA with the following primers: F: 5′-AGAGTTTGATCCTGGCTCAG-3′ and R: 5′- GGTTACCTTGTTACGACTT-3′. 20-25 flies from the same cohort were shifted to 29°C for 2-3 days to express either GFP or GFP and *N^RNAi^* with *esg^ts^* to assess tumor growth in midguts with normal or low luminal bacteria levels.
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![Tissue stress promotes ISC tumor initiation\
(a) System to independently express transgenes in ECs with *Myo1A^ts^* and subsequently initiate ISC- derived tumors by heat shock- induced Flp-FRT mediated recombination.\
(b) Mean number of tumors per midgut with s.e.m. 14 days (18°C) after tumor induction following GFP (n=20 midguts), JNKK (*hep*) (n=12 midguts, Mann-Whitney: p=0.0203) or activated JNKK (*hep^Act^*) (n=10 midguts, Mann-Whitney: p=0.0002) expression in ECs with *Myo1A^ts^* for 5 days (29°C). Midguts pooled from 2 independent experiments.\
(c) Mean percent of flies with tumors with s.e.m. from n=3 independent experiments 14 days (18°C) after tumor induction following GFP, JNKK (*hep*) or activated JNKK (*hep^Act^*) (paired t-test: p=0.0076) expression in ECs with *Myo1A^ts^* for 5 days (29°C).\
(d) Cells per *neur^IF65/−^* tumor with mean (red line) and s.e.m. 14 days (18°C) after tumor induction following GFP (n=13 tumors pooled from 20 midguts), JNKK (*hep*) (n=31 tumors pooled from 12 midguts) or activated JNKK (*hep^Act^*) (n=77 tumors pooled from 10 midguts) expression in ECs with *Myo1A^ts^* for 5 days (29°C). Midguts pooled from 2 independent experiments.\
(e) Mean percent of flies with tumors with s.e.m. from n=3 independent experiments in flies expressing GFP and *N^RNAi^* or *N^RNAi^*, *Cyclin E* (*CycE*) and *cdc25/string* (*stg*) (paired t-test: p= 0.0185) with *esg^ts^* (weak) for 3 days.\
(f) Mean percent of flies with tumors with s.e.m. from n=3 independent experiments after being fed food alone, *P.e.* containing food (paired t-test: p=0.0034), sucrose alone or *P.e.* containing sucrose (paired t- test: p=0.0007) for 1 day prior to tumor induction by expressing *N^RNAi^* with *esg^ts^* (weak) for 3 days (food alone).](emss-64072-f0001){#F1}

![Spi/EGFR/MAPK signaling is induced in ISC tumors and the niche\
(a-d) Di-phosphorylated ERK (a', c'; b, d, red) in midguts expressing GFP (a; b, green) or GFP and *N^RNAi^* (c; d, green) with *esg^ts^* for 2 days.\
(e-f) β-galactosidase (e,f; e',f', red) in midguts of flies bearing *vn-lacZ* (*vn^P1749^*) and expressing GFP (e', green) or GFP and *N^RNAi^* (f', green) with *esg^ts^* for 2 days.\
(g) Mean normalized expression (NE) value (RPKM, log~2~) from n=2 independent experiments of EGFR ligand (*spi, Krn, vn*) and signaling target (*aos*) mRNA determined by mRNA sequencing of midguts expressing GFP (control, red) or GFP and *N^RNAi^* (blue) with *esg^ts^* for 3 days. The adjusted fold change in gene expression in tumorous midguts (blue), normalized to control midguts (red), is indicated. The Benjamini-Hochberg adjusted p-value for *spi* is 7.71e-322; *vn*, p= 3.25e-66; aos, p= 2.84e-264.\
(h) Mean normalized expression (NE) value (RPKM, log2) from n=2 independent experiments of EGFR ligand (*spi, Krn* and *vn*) and signaling target (aos) mRNA determined by mRNA sequencing of *esg^+^* cells sorted from control midguts expressing GFP (red) or from tumorous midguts expressing GFP and *N^RNAi^* (blue) with *esg^ts^* for 3 days. The adjusted fold change in gene expression in sorted *esg^+^* tumor cells (blue), normalized to *esg^+^* cells from control midguts, is indicated. Benjamini-Hochberg corrected p-value for *spi* is 0.02924066; *aos*, 4.52e-05.\
NS, not significant. DNA is in a'' and c''; e' and f' (blue). Scale bars in a-a'', 35 μm; b, 10 μm; cc'', 40 μm; d, 10 μm; e-e', 35 μm and f-f', 45 μm.](emss-64072-f0002){#F2}

![ISC tumor initiation and outgrowth requires autonomous Spi/EGFR signaling\
(a-c) Phosphorylated histone H3 Ser10 (red) and GFP (green) after expression of *N^RNAi^* (a), *EGFR^RNAi^* and *N^RNAi^* (b) and *spi^RNAi^* and *N^RNAi^* (c) with *esg^ts^* for 3 days.\
(d) Phosphorylated histone H3 Ser10 (red) and GFP (green) after expression of *spi^RNAi^* and *N^RNA^*^i^ with *esg^ts^* for 14 days.\
(e) Mean number of phosphorylated histone H3 Ser10 positive cells per midgut with s.e.m. after expression with *esg^ts^* of *N^RNAi^* and GFP (n=30 midguts), *N^RNAi^* and *Egfr^RNAi^* (n=30 midguts, Mann-Whitney: p=0.0001), *N^RNAi^* and *spi^RNAi^* for 3 (n=33 midguts, Mann-Whitney: p\<0.0001) or 30 days, and *N^RNAi^* and *Mkp3* for 5 or 10 days. Midguts were pooled from 3 independent experiments.\
(f) Survival after expression of GFP alone (control), *spi^RNAi^*, *N^RNAi^*, and *N^RNAi^* and *spi^RNAi^* with *esg^ts^* (n=100 flies per genotype pooled from 2 independent experiments).\
DNA is a-d (blue). Scale bars in a-c, 40 μm; d, 50μm.](emss-64072-f0003){#F3}

![Growing ISC tumors induce changes in the niche\
(a-b) Transmission electron micrograph of anterior midgut expressing GFP (a) or *N^RNAi^* (b) with *esg^ts^* for 3 days.\
(c) System to independently initiate ISC- derived tumors by heat shock- induced Flp-FRT mediated recombination and subsequently express transgenes in ECs with *Myo1A^ts^*.\
(d-e) β-galactosidase (d,e; d',e', red) in midguts of flies bearing *puc-lacZ* and expressing GFP (d', green) or GFP and *Dl^RNAi^* (e', green) with *esg^ts^* for 8 days. High β-galactosidase (e; e', red; arrow) was observed in ECs adjacent to ISC tumors; lower β-galactosidase (arrowhead) in ECs further away.\
(f-g) β-galactosidase (f,g; f',g', red) in midguts of flies bearing *ex-lacZ* and expressing GFP (f', green) or GFP and *N^RNAi^* (g', green) with *esg^ts^* (weak) for 7 days.\
(h-j) Cells per *neur^IF65/−^* tumor amongst ECs expressing GFP (control, n=35 tumors from 12 midguts, skewness= 1.117, kurtosis= 0.4573) or GFP and *p35* (n=42 tumors from 28 midguts, p=0.0019, skewness= 1.586, kurtosis= 1.707) at 29 °C (h); GFP (control, n=83 tumors from 32 midguts, skewness= 2.650, kurtosis= 8.662), GFP and *bsk^K53R^* (n=82 tumors from 45 midguts, p=0.0346, skewness= 3.805, kurtosis= 17.430), GFP and *puc* (n=29 tumors from 19 midguts, p=0.0046), GFP and *bsk^RNAi^* (n=57 tumors from 44 midguts, p\<0.0001, skewness= 3.857, kurtosis= 16.530) or GFP and *hep* (n=191 tumors from 68 midguts, p=0.0045, skewness= 1.508, kurtosis= 2.082) at 29 °C or GFP (control, n=51 tumors from 23 midguts, skewness= 2.414 and kurtosis= 5.719) or GFP and *hep^Act^* (n=42 tumors from 14 midguts, p\<0.0001, skewness= 1.413 and kurtosis= 1.724) at 25°C (i); GFP (control, n=79 tumors from 41 midguts, skewness= 2.017, kurtosis= 4.577), GFP and *wts* (n=92 tumors from 33 midguts, p=0.0088) or GFP and *yki^RNAi^* (n=55 tumors from 17 midguts, p\<0.0001, skewness= 5.693, kurtosis= 36.85) at 29°C (j) with *Myo1A^ts^,* 7-8 days.\
In h-j, midguts were pooled from 3 independent experiments; p-values from Mann-Whitney test; mean (red line) and s.e.m. (blue) are shown. DNA in d', e', f' (blue). Scale bars in a-b, 5 μm; in d-d', 25 μm; in e-e', 20μm; in f-g', 60 μm.](emss-64072-f0004){#F4}

![ISC tumor growth induces non-autonomous ISC proliferation\
(a) Phosphorylated histone H3 Ser10 (red) inside and outside (arrows) of 4 day *neur^IF65^* clones (green).\
(b) Mean number with s.e.m. of mitoses per midgut found inside (GFP^+^, green; for *neur^−^* clone, Mann-Whitney: p=0.0011) and outside (GFP^−^, grey; for *neur^−^* clone, Mann-Whitney: p=0.0012) of 4 day control (n=31 midguts) or *neur^IF65/−^* clones (n=24 midguts). Midguts were pooled from 3 independent experiments.\
(c) Phosphorylated histone H3 Ser10 (red) in midguts expressing GFP (green) and *N^RNAi^* with *esg^ts^* for 2 days.\
(d) Mean percent of phosphorylated histone H3 Ser10 positive cells with s.e.m. found in the tumor interior or at the tumor boundary (n=3 fields; fields were selected from 3 posterior midguts from 2 independent experiments, paired t-test: p= 0.0080) in flies expressing GFP and *N^RNAi^* with *esg^ts^* for 2 days.\
DNA in a, c (blue). Scale bar in a, 40 μm; c, 35 μm.](emss-64072-f0005){#F5}

![ISC tumors co-opt niche derived signals for their growth\
(a-c) Flourescent in situ hybridization to *upd3* mRNA (a-c'; a',b',c', red) in control midguts expressing GFP (a', green) or GFP and *N^RNAi^* (b', c', green) with *esg^ts^* for 2 days. ECs near ISC tumors expressed *upd3* (c-c', arrows).\
(d) D-GFP (d, green) and Delta (d', red) in midguts of flies bearing 10X-STAT-D-GFP and expressing *N^RNAi^* with *esg^ts^* (without *UAS-GFP*) for 5 days.\
(e) Mean normalized expression (NE) value (RPKM, log~2~) from n=2 independent experiments of cytokine (*upd1-3*) and JAK-STAT target (*Socs36*) mRNA determined by mRNA sequencing of whole midguts expressing GFP (control, red) and GFP and *N^RNAi^* (blue) with *esg^ts^* for 3 days. The adjusted fold change in gene expression in midguts bearing tumors (blue), normalized to control midguts (red), is indicated. The Benjamini-Hochberg adjusted p-value for *upd2*, *upd3* and *Soc36E* is 7.71e-322. NS, not significant.\
(f) Mean number of phosphorylated histone H3 Ser10 positive cells per midgut after expression of *N^RNAi^* (n=48 midguts), *Upd1* and *N^RNAi^* (n=45 midguts, p=0.0011), and *N^RNAi^* and *dome^ΔCYT^* (n=39 midguts, p\<0.0001) with *esg^ts^* for 2 days.\
(g) Mean number of phosphorylated histone H3 Ser10 positive cells per midgut after expression of *N^RNAi^* with *esg^ts^* (weak) for 14 days in control flies (n=27 midguts) and flies mutant for *upd2* (*upd2Δ*, n=25 midguts, p=0.0176)*, upd3* (*upd3Δ*, n=34 midguts, p\<0.0001) and *upd2* and *upd3* (*upd2-3Δ*, n=28 midguts, p\<0.0001).\
(h) Cells per *neur^IF65/−^* tumor amongst ECs expressing GFP (control, n=101 tumors from 38 midguts, skewness= 2.097, kurtosis= 4.754) or RNAis against *upd2*(1) (n = 41 tumors from 35 midguts, p=0.0181, skewness= 3.681, kurtosis= 15.980) and *upd2*(2) (n=27 tumors from 23 midguts, p=0.0033, skewness= 3.068, kurtosis= 10.720) and *upd3*(1) (n=55 tumors from 36 midguts, p=0.0233, skewness= 2.742, kurtosis= 8.061 and *upd3*(2) (n=37 tumors in 25 midguts, p=0.0010) with *Myo1A^ts^* for 7 days.\
In f-h, midguts were pooled from 3 independent experiments; p-values from Mann-Whitney test; mean with s.e.m. are shown. Scale bars in a-b', 40 μm; in c-c', 30 μm; in d-d', 25 μm. DNA in c', d-d' (blue).](emss-64072-f0006){#F6}

![Tumor- induced enterocyte detachment induces JNK and Yki activity and Upd3 expression\
(a) Mean percent with s.e.m. of β-galactosidase (β-gal)- positive *N^−^* tumor-adjacent enterocytes that were fully detached, partially detached or fully attached in midguts bearing *upd3.1-lacZ* (yellow, n=4 z-stacks), *puc-lacZ* (green, n=3 z-stacks) or *ex-lacZ* (red, n=3 z-stacks) and expressing GFP and *N^RNAi^* with *esg^ts^* for 3 days.\
(b) Mean percent with s.e.m. of *N^−^* tumor-adjacent enterocytes in each category (fully detached, partially detached and fully detached) that had high β-galactosidase positivity, in midguts bearing *upd3.1-lacZ* (yellow, n=4 z-stacks), *puc-lacZ* (green, n=3 z-stacks) or *ex-lacZ* (red, n=3 z-stacks) and expressing GFP and *N^RNAi^* with *esg^ts^* for 3 days.\
(c) β-galactosidase (red) in midguts bearing *upd3.1-lacZ* expressing GFP (green) and *N^RNAi^* with *esg^ts^* for 3 days.\
(d) β-PS1 integrin (d; d', magenta) in midguts bearing *puc-lacZ* and expressing *Mmp-1* and GFP (d', green) with *Myo1A^ts^* for 2 days. β-galactosidase (d''; d''', red (nuclear)) in ECs and phalloidin (Actin) (d''; d''', red) in VM of midguts bearing *puc-lacZ* and expressing *Mmp-1* and GFP (d''', green) with *Myo1A^ts^* for 2 days.\
(e) β-galactosidase (e; e', red) in ECs and phalloidin (e', white) in VM of midguts bearing *ex-lacZ* and expressing *Mmp1* and GFP (e', green) with *Myo1A^ts^* for 2 days.\
f) β-galactosidase (f; f', red) in ECs of midguts bearing *upd3.1-lacZ* and expressing *Mmp1* and GFP (f', green) with *Myo1A^ts^* for 2 days.\
In a-b, z-stacks acquired from 2 independent experiments. DNA in c', d', d''', e' and f' (blue). Scale bars in c-c', 40μm; d-d''', 35μm; e-e', 25 μm; f-f', 60μm.](emss-64072-f0007){#F7}

![Integrin loss from enterocytes induces JNK activity and promotes ISC tumor growth\
(a-b) β-galactosidase (nuclear) (a,b ; a',b', white) and β-PS1 (a', b', red) in ECs of midguts bearing *puc-lacZ* and expressing GFP (a', green) or GFP and *αPS3+4^RNAi^* (b', green) with *Myo1A^ts^* for 7 days.\
(c) Mean number with s.e.m. of phosphorylated histone H3 Ser10 positive cells per midgut in flies expressing GFP (control, n=18 midguts), GFP and *αPS3+4^RNAi^* (n=19 midguts, Mann-Whitney test: p\<0.0006) or *βPS1^RNAi^* (n=17 midguts, Mann-Whitney: p\<0.0004) with *Myo1A^ts^* for 7 days.\
(d) β-PS1 integrin (d, d', red) in midguts bearing *neur^IF65/−^* tumors (yellow dashed line) and expressing GFP (d', green) with *Myo1A^ts^* for 10 days. Arrowheads indicate detached ECs apical to tumors that have lost basal β-PS1 expression.\
(e) Cells per *neur^IF65/−^* tumor with mean (red line) and s.e.m. amongst ECs expressing either GFP (control, n=74 tumors from 35 midguts, skewness= 1.876, kurtosis= 4.283) or GFP and *αPS1^RNAi^* (n=63 tumors from 10 midguts, Mann-Whitney: p= 0.0116, skewness= 1.221, kurtosis= 1.126) or GFP and *βPS1^RNAi^* (n=54 tumors from 23 midguts, Mann-Whitney: p= 0.0004, skewness= 1.262, kurtosis= 1.093) with *Myo1A^ts^* for 7 days.\
(f) Model for *Notch*-dependent tumorigenesis in the adult *Drosophila* midgut.\
In c and e, midguts pooled from 3 independent experiments. DNA in a', b', d-d' (blue). The scale bars in a-b' and d-d', 20 μm.](emss-64072-f0008){#F8}
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